Rubella Antibody Seroconversion Completed Phase 4 Trials for Rotavirus Vaccine (DB10276)

IndicationStatusPhase
DBCOND0059960 (Rubella Antibody Seroconversion)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01700621Coadministration of Measles-rubella and Rotavirus VaccinesPrevention